Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

EPA/BOI stock hub

EPA/BOI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EPA/BOIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

477.5M

Euronext Paris

Market data

Live price

Current market quote for this ticker.

Current price

EPA/BOI

In the news

Latest news · EPA/BOI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.4

P25 n/aP50 n/aP75 n/a

Trailing P/E14.6

P25 n/aP50 n/aP75 n/a

ROE8.5

P25 n/aP50 n/aP75 n/a

ROIC11.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EPA/BOI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

243

Groups with data

Currency

EUR

Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	FR
Employees	2,634
Employees Change	-137%
Employees Change Percent	-4.94
Enterprise value	EUR 429.6M
Exchange	Euronext Paris
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	FR0000061129
Last refreshed	2026-05-10
Market cap	EUR 477.5M
Price	EUR 27.5
Price currency	EUR
Rev Per Employee	200,522.61x
Sector	Healthcare
Sic	2834
Symbol	epa/BOI
Website	https://www.boiron.fr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.84%
EV Earnings	13.16x
EV/EBIT	8.33x
EV/EBITDA	6.95x
EV/FCF	11.38x
EV/Sales	0.86x
FCF yield	7.91%
Forward P/E	13.38x
P/B ratio	1.22x
P/E ratio	14.63x
P/S ratio	0.95x
PE Ratio10 Y	22.85x
PE Ratio3 Y	26.1x
PE Ratio5 Y	24.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	10.29%
EBITDA Margin	11.35%
FCF margin	7.53%
Gross margin	72.98%
Gross Profit	EUR 365.7M
Gross Profit Growth	-1.72%
Gross Profit Growth Q	-3.35%
Gross Profit Growth3 Y	1.39%
Gross Profit Growth5 Y	-0.88%
Net Income	EUR 32.6M
Net Income Growth	187.96%
Net Income Growth Q	165.86%
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Net Income Growth3 Y	11.28%
Net Income Growth5 Y	-7.27%
Pretax Margin	8.55%
Profit Margin	6.51%
Profit Per Employee	EUR 13,062
Profitable Years	25
ROA	5.47
Roa5y	4.69
ROCE	10.96
ROE	8.47
Roe5y	6.44
ROIC	11.39
Roic5y	11.49

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-4.29%
Cagr15y	3.69%
Cagr1y	15.98%
Cagr20y	6.17%
Cagr3y	-1.38%
Cagr5y	0.56%
Div CAGR10	-1.05%
Div CAGR3	7.06%
Div CAGR5	7.28%
EPS Growth	188
EPS Growth Q	165.9
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth3 Y	11.28
EPS Growth5 Y	-7.27
FCF Growth	21.28%
FCF Growth Q	-33.55%
FCF Growth3 Y	4.6%
FCF Growth5 Y	8.14%
OCF Growth	34.67%
OCF Growth Q	1.2%
OCF Growth10 Y	-2.46%
OCF Growth3 Y	7.7%
OCF Growth5 Y	9.43%
Revenue Growth	2.78x
Revenue Growth Q	-1.45x
Revenue Growth Years	1x
Revenue Growth3 Y	1.32x
Revenue Growth5 Y	-0.64x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.85
Assets	EUR 602.8M
Cash	EUR 79.3M
Current Assets	EUR 293.5M
Current Liabilities	EUR 132.1M
Debt	EUR 31.5M
Debt EBITDA	EUR 0.51
Debt Equity	EUR 0.08
Debt FCF	EUR 0.83
Equity	EUR 392.8M
Interest Coverage	46.42
Liabilities	EUR 210M
Long Term Assets	EUR 309.3M
Long Term Liabilities	EUR 78M
Net Cash	EUR 47.9M
Net Cash By Market Cap	EUR 10.02
Net Cash Growth	-3.79%
Net Debt EBITDA	EUR -0.84
Net Debt Equity	EUR -0.12
Net Debt FCF	EUR -1.27
Tangible Book Value	EUR 272.9M
Tangible Book Value Per Share	EUR 15.72
WACC	5.35

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.22
Inventory Turnover	1.36
Net Working Capital	EUR 94.8M
Quick ratio	1.42
Working Capital	EUR 161.4M
Working Capital Turnover	EUR 3.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	12.5%
Dividend Growth Years	0%
Dividend per share	EUR 1.35
Dividend Years	35
Dividend Yield	4.91%
Ex Div Date	2026-06-03
Last Dividend	EUR 1.35
Payout Frequency	Annual
Payout Ratio	63.83%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-35.48%
1Y total return	15.97%
200-day SMA	26.85
3Y total return	-4.09%
50-day SMA	26.48
50-day SMA vs 200-day SMA	50under200
5Y total return	2.82%
All Time High	112.8
All Time High Change	-75.62%
All Time High Date	2015-04-10
All Time Low	1.69
All Time Low Change	1,527.22%
All Time Low Date	1992-01-08
ATR	1.01
Beta	0.23
Beta1y	0.1
Beta2y	0.23
Ch YTD	-9.24
High	28
High52	32.25
High52 Date	2025-12-04
High52ch	-14.73%
Low	26.8
Low52	20.85
Low52 Date	2025-08-15
Low52ch	31.89%
Ma50ch	3.86%
Price vs 200-day SMA	2.42%
RSI	56.48
RSI Monthly	44.9
RSI Weekly	51.39
Sharpe ratio	0.53x
Sortino ratio	1.21
Total Return	4.91%
Tr YTD	-9.24
Tr15y	72.28%
Tr1m	-1.08%
Tr1w	-1.79%
Tr3m	-6.78%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 51.6M
Operating Income Growth	-7.04
Operating Income Growth Q	-11.65
Operating Income Growth3 Y	5.78
Operating Income Growth5 Y	-1.7
Operating margin	10.29

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,501,403%
Net Borrowing	-4,847,000
Shares Institutions	2.94%
Shares Out	17,362,275
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 37.8M
Average Volume	5,466.55x
Bv Per Share	22.62
CAPEX	EUR -15.5M
Ch10y	-61.41
Ch15y	-7.72
Ch1m	-1.08
Ch1w	-1.79
Ch1y	10.22
Ch20y	57.23
Ch3m	-6.78
Ch3y	-31.59
Ch5y	-29.94
Ch6m	1.85
Change	-1.43%
Change From Open	2.61
Close	27.9
Days Gap	-3.94
Depreciation Amortization	5,279,000
Dollar Volume	87,010
Earnings Date	2026-07-17
EBIT	EUR 51.6M
EBITDA	EUR 56.9M
EPS	EUR 1.88
F Score	5
FCF	EUR 37.8M
FCF EV Yield	8.79x
FCF Per Share	EUR 2.17
Financing CF	-24,394,000
Fiscal Year End	December
Founded	1,932
Goodwill	89,604,000
Graham Number	30.93439
Graham Upside	12.49
Income Tax	EUR 10.2M
Investing CF	-23,388,000
Is Primary Listing	1
Last Earnings Date	2025-10-29
Last Report Date	2025-12-31
Last Split Date	2003-07-01
Last Split Type	Forward
Lynch Fair Value	EUR 9.4
Lynch Upside	-65.82
Ma150	28.02
Ma150ch	-1.85%
Ma20	26.34
Ma20ch	4.4%
Net CF	6,411,000
Next Earnings Date	2026-07-17
Open	26.8
P FCF Ratio	12.65
P OCF Ratio	8.97
Payment Date	2026-06-05
Position In Range	58.33
Ppne	150,457,000
Price Date	2026-05-08
Price EBITDA	EUR 8.4
Ptbv Ratio	1.75
Relative Volume	0.58x
Revenue	501,106,000x
Tax By Revenue	2.04x
Tax Rate	23.84%
Tr20y	231%
Tr6m	1.85%
Volume	3,164

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

EPA/BOI dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.9%

$1.35 annual per share

Payout ratio

+63.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+7.3%

0 consecutive years of growth

Total shareholder yield

+4.9%

Next ex-dividend date: 2026-06-03

Performance

EPA/BOI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EPA/BOI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.9%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

EPA/BOI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.5

Neutral momentum band

Price vs 200-day MA

+2.4%

50/200-day relationship not available

Beta (5Y)

0.23

Less volatile than the market

Sharpe ratio

0.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EPA/BOI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current epa/BOI stock rating?

epa/BOI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full epa/BOI analysis?

The full report lives at /stocks/epa/BOI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for epa/BOI?

The latest report frames epa/BOI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the epa/BOI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.